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Background:  Patients (pts) with severely decreased left ventricular ejection fraction (LVEF < 35%) are at high risk for the occurrence of 
malignant ventricular arrhythmias and sudden cardiac death (SCD). Since most risk markers have a low positive predictive accuracy, a more precise 
characterization of risk factors for occurring VT/VF in these pts is critical.
The aim of the present study was to determine, if pts undergoing appropriate ICD intervention hold alterations in activity of DPIV and of renin-
angiotensin-aldosterone system (RAAS) proteases before VT/VF occurrence.
Methods:  57 Patients (53 male, mean age 64.9 years, mean LVEF 26 ± 5%) with ischemic (n = 49), or dilated cardiomyopathy who had implanted 
an ICD for primary prevention, were consecutively included. Patients were assessed for appropriate ICD interventions during a mean follow-up 
of 365 ± 90 days. Serum levels of dipeptidyl-aminopeptidase IV (DPIV), aminopeptidase N (APN), aminopeptidase B (APB), insulin regulated 
aminopeptidase (IRAP), and angiotensin-converting enzyme 2 (ACE2) were determined at study entry.
Results:  The average time until the first occurrence of an arrhythmic-event was 131 days.
Pts with appropriate ICD intervention (n = 16) had higher serum activities of IRAP (0.227 ± 0.048 vs 0.183 ± 0.064; p = 0.007) and DPIV (2.134 
± 0.655 vs 1.728 ± 0.417; p = 0.032), than patients without appropriate ICD intervention (n = 41). Furthermore, ACE2 activity was significantly 
different between these two groups (p = 0.037).
APN activity showed a tendency to be higher in pts with appropriate ICD intervention (2.522 ± 1.087 vs 1.935 ± 0.576; p = 0.055). Stepwise logistic 
regression indicated DPIV activity to have the highest OR (4.58, CI 95%: 1.19 - 17.63; p = 0.026) for prediction of appropriate ICD interventions. 
Similarly, it confirmed APN (p = 0.032) and IRAP (p = 0.028) as predictors.
Conclusion: Our prospective study shows that alterations in DPIV as well as in several RAAS-enzyme activities are detectable in patients 
undergoing appropriate ICD intervention during a one year follow-up. Our data suggests several enzyme activities as being predictive for appropriate 
ICD interventions, but needs to be validated in larger cohorts.
